The International Prognostic Index Assessed at Relapse Predicts Outcomes of Autologous Transplantation for Diffuse Large-Cell Non-Hodgkin’s Lymphoma in Second Complete or Partial Remission
Authors:
- William ThomasWTWilliam Thomas
- Todd E. DeForTDTodd E. DeFor
- Daniel J. WeisdorfDWDaniel J. Weisdorf
- Linda J. BurnsLBLinda J. Burns
Open Access
- 1 April 2007
- journal article
- Published by Elsevier in Transplantation and Cellular Therapy
- Vol. 13 (4) , 486-492
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Prognostic value of the age-adjusted International Prognostic Index in chemosensitive recurrent or refractory non-Hodgkin's lymphomas treated with high-dose BEAM therapy and autologous stem cell transplantationLeukemia & Lymphoma, 2005
- Autologous transplantation for diffuse aggressive Non-Hodgkin lymphoma in first relapse or second remissionTransplantation and Cellular Therapy, 2004
- Age-adjusted International Prognostic Index predicts autologous stem cell transplantation outcome for patients with relapsed or primary refractory diffuse large B-cell lymphomaBlood, 2003
- The Role of Intensive Therapy and Autologous Blood and Marrow Transplantation for Chemotherapy‐Sensitive Relapsed and Primary Refractory Non‐Hodgkin’s Lymphoma: Identification of Major Prognostic GroupsBritish Journal of Haematology, 1996
- Autologous Bone Marrow Transplantation as Compared with Salvage Chemotherapy in Relapses of Chemotherapy-Sensitive Non-Hodgkin's LymphomaNew England Journal of Medicine, 1995
- A Predictive Model for Aggressive Non-Hodgkin's LymphomaNew England Journal of Medicine, 1993
- Prognostic factors for treatment outcome in autotransplantation of intermediate-grade and high-grade non-Hodgkin's lymphoma with cyclophosphamide, carmustine, and etoposide.Journal of Clinical Oncology, 1993
- Comparison of a Standard Regimen (CHOP) with Three Intensive Chemotherapy Regimens for Advanced Non-Hodgkin's LymphomaNew England Journal of Medicine, 1993
- Treatment of Non-Hodgkin's LymphomaNew England Journal of Medicine, 1993
- Comparison of a Second-Generation Combination Chemotherapeutic Regimen (m-BACOD) with a Standard Regimen (CHOP) for Advanced Diffuse Non-Hodgkin's LymphomaNew England Journal of Medicine, 1992